InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Egros Fabrice, Director. Director active across 2 companies, notably Syndax Pharmaceuticals Inc. In total, 8 filings have been recorded. The latest transaction was disclosed on 2 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is free.
Declarations8 total
016,000 shares0
Common Stock
SEC:0001562180-22-001072·
016,000 shares0
Common Stock
SEC:0001562180-22-001072:0·
€110,43014,000 shares@ €7.88790.0062% mcap51.2% of flow
Common Stock
SEC:0001562180-21-007180·
€110,43014,000 shares@ €7.88790.0062% mcap22.0% of flow
Common Stock
SEC:0001562180-21-007180:0·
€105,27315,635 shares@ €6.73310.0059% mcap48.8% of flow
Common Stock
SEC:0001562180-21-005491·
€105,27315,635 shares@ €6.73310.0059% mcap21.0% of flow
Common Stock
SEC:0001562180-21-005491:0·
€70,24511,926 shares@ €5.8901100.0% of flow
Common Stock
SEC:0001562180-21-003670·
€70,24511,926 shares@ €5.89010.0039% mcap14.0% of flow
Common Stock
SEC:0001562180-21-003670:0·
8 of 8 declarations
About Egros Fabrice
Fabrice Egros is a Director at Syndax Pharmaceuticals Inc. In this role, he participates in the governance of the company, which focuses on developing innovative oncology treatments. Egros contributes to strategy development and operational oversight to ensure the company's success.
